🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

Recruitingn/aAges 35 Years - anyAllNational Minority Quality Forum
NCT07461493 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health informat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Registry Inclusion Criteria: 1. Adults 35 years and older. 2. Participant provides written informed consent prior to initiation of any study procedures. 3. Participant understands the purpose and procedures of the study. 4. Participant agrees that demographic data, medical history, and social determinants of health on the enrollment questionnaires can be used for research purposes. 5. Participant agrees to the release and review of their electronic medical record. 6. Participant agrees to be followed for the duration outlined in this protocol. Biorepository 1. Participant is able, in the investigator's professional opinion, to provide up to 100 mLs of whole blood at the Screening Visit and at the Interim Visits. 2. Participant is a healthy, nonpregnant adult. 3. Participant weighs at least 110 pounds. 4. Participant has negative viral test results. Exclusion Criteria: Registry 1. Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent. 2. Participants who are unable to understand the study protocol or unable to give informed consent. 3. Participants under the age of 35 at the time of enrollment. Biorepository 1. Women of childbearing age that think they may be pregnant or are planning to get pregnant within the study timeframe. 2. Participants who weigh under 110 pounds. 3. Participants who, in the opinion of the investigator, are unable to provide biospecimen samples.
💊

What it tests

  • Not listed
📍

Where

2 sites
Life in 3D Health Services
Flint, United States
Grace Clinic
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy